Capital Region Medical Research Institute

Established in 2015, the Capital Region Medical Research Institute (CRMRI) supports innovative and collaborative approaches to education, research, and medical care, especially in the field of urology. 

The Institute is designed to bring together scientists and physicians to discover new information about healthcare treatments and practices that will benefit patients and improve outcomes.

The Institute Grants Program was funded by a gift generously donated by the former Capital Region Medical Research Foundation, Inc. (CRMRF), an independent nonprofit organization previously established to advance health research in the Capital Region.


How You Can Help

Your gift to the Capital Region Medical Research Institute (CRMRI) promotes research in our area.  It provides small grants focused on urological health to Capital Region scientists studying innovative treatments or diagnostics, and disease prevention strategies.  The goal is to encourage research in urological health and illness by both funding young researchers to pursue careers in urological health and illness and by encouraging established researchers not in the field to consider adopting their methodologies to questions that are related to the field of urology.


Grants Program


Application Information

The CRMRI Research Grants Program was established to fund Capital Region scientists studying innovative treatments or diagnostics, disease prevention strategies and promotion of population health, with a focus on urological health. The goal is to provide initial funding in order to develop new areas of research or new partnerships that have a strong possibility of leading to additional funding from other sources. While this program is primarily intended to support new or young investigators, established investigators may apply if they are moving into new areas of research.


Previously Funded Projects
  • An assessment of intra and inter-observer variability in scrotal ultrasound measurement of testicular volume
  • The effects of varicocelectomy and selective estrogen receptor modulators on Leydig cell function, as determined by insulin like growth factor 3
  • Evaluation of the process and outcomes of care for patients with chronic pelvic pain
  • A novel isoform of Bruton's tyrosine kinase in prostate cancer
  • Rose of TAZ in obstructive uropathy